• Sakai Chemical Industry received SH1's request to exercise all 10,126 fourth series stock acquisition rights, representing 100% of the issue.
• Exercise completion and issuance of 1,012,600 new shares are expected by October 26, 2026.
• Proceeds of 2 billion yen will be reserved for acquisitions, mainly to expand growth businesses.
• The annual dividend forecast remains unchanged at 160 yen per share despite the increased share count.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sakai Chemical Industry Co. Ltd. published the original content used to generate this news brief on October 26, 2026, and is solely responsible for the information contained therein.